imipramine has been researched along with Lupus Erythematosus, Systemic in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sugiyama, T | 1 |
Kiwamoto, H | 1 |
Esa, A | 1 |
Park, YC | 1 |
Kaneko, S | 1 |
Kurita, T | 1 |
1 other study available for imipramine and Lupus Erythematosus, Systemic
Article | Year |
---|---|
[Neurogenic bladder in patients with SLE].
Topics: Adolescent; Female; Humans; Imipramine; Lupus Erythematosus, Systemic; Middle Aged; Myelitis, Transv | 1987 |